Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Gross Profit: 2014-2025

Historic Gross Profit for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $1.2 million.

  • AC Immune's Gross Profit fell 96.01% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 82.53%. This contributed to the annual value of $28.7 million for FY2025, which is N/A change from last year.
  • As of Q3 2025, AC Immune's Gross Profit stood at $1.2 million, which was down 25.59% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Gross Profit ranged from a high of $29.4 million in Q3 2024 and a low of -$1.6 million during Q1 2022.
  • For the 3-year period, AC Immune's Gross Profit averaged around $3.2 million, with its median value being $399,271 (2023).
  • The largest annual percentage gain for AC Immune's Gross Profit in the last 5 years was 92,595.18% (2022), contrasted with its biggest fall of 1,827.07% (2022).
  • AC Immune's Gross Profit (Quarterly) stood at $81,338 in 2021, then soared by 401.54% to $407,943 in 2022, then dropped by 8.80% to $372,027 in 2023, then spiked by 248.88% to $1.3 million in 2024, then slumped by 96.01% to $1.2 million in 2025.
  • Its Gross Profit was $1.2 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.1 million in Q1 2025.